Clariant starts 2018 with significant growth in sales and EBITDA
April 25 2018 - 1:00AM
Clariant AG / Clariant starts 2018 with significant growth in
sales and EBITDA . Processed and transmitted by Nasdaq Corporate
Solutions. The issuer is solely responsible for the content of this
announcement.
-
First quarter sales rose by
7 % in local currency to CHF 1.722 billion
-
EBITDA before exceptional items
improved significantly by 7 % in Swiss francs
-
EBITDA margin before
exceptional items remained stable at a good 15.6 %
-
2018 outlook
confirmed
|
|
|
"In the
first three months of 2018, Clariant delivered very good 7 %
growth, both in sales and profitability", said CEO Hariolf
Kottmann. "All our Business Areas contributed to this progress
which was mainly driven by volumes. The turnaround of the Catalysis
business has been confirmed and also the Oil & Mining Services
business is showing signs of improvement, while Care Chemicals
continued its excellent development and Plastics & Coatings is
performing in line with expectations. For 2018, we are on track to
achieve our targets."
Key Financial Data
|
|
First Quarter |
in CHF million |
|
|
|
|
2018 |
2017 |
% CHF |
% LC |
Sales |
|
|
|
|
1 722 |
1 602 |
7 |
7 |
EBITDA before
exceptional items |
|
|
|
|
268 |
250 |
7 |
2 |
-
margin |
|
|
|
|
15.6 % |
15.6 % |
|
|
First quarter 2018 - Further sales and EBITDA
improvement
Muttenz, April 25, 2018 - Clariant, a world leader in specialty
chemicals, today announced first quarter 2018 sales of
CHF 1.722 billion compared to CHF 1.602 billion
in the first quarter of 2017. This corresponds to 7 % growth
in local currency as well as in Swiss francs. All Business Areas
contributed to this sales growth, with particular strength in
Catalysis and Care Chemicals. Organic sales rose by 5 % in
local currency driven by higher volumes and supported by a positive
pricing effect.
All
geographic regions contributed to the progression in the first
quarter. Growth in local currency was most pronounced in Asia at
15 % driven by a substantial expansion in China while sales in
Latin America rose by 11 % as a result of the recovering
macroeconomic environment. Sales in North America advanced by
5 % and in the Middle East & Africa by
4 % in local currency. Europe grew by a solid 2 % despite
a very strong comparable base.
In Care
Chemicals and Catalysis, the excellent sales expansion continued.
Sales in Care Chemicals rose by 9 % in local currency mainly
supported by Consumer Care and Aviation. Catalysis sales advanced
by a vigorous 36 % in local currency with excellent organic
sales growth of 19 %.
Natural
Resources sales grew by 2 % in local currency amid the
progressing oil market recovery. Plastics & Coatings
delivered another 2 % local currency growth against a strong
comparable base. All three Business Units contributed to the
advancement.
EBITDA
before exceptional items rose by 7 % in Swiss francs and
reached CHF 268 million compared to
CHF 250 million in the previous year. The upswings
particularly in Catalysis but also in Care Chemicals as well as the
strong performance in Plastics & Coatings led to the
profitability enhancement.
The
corresponding EBITDA margin before exceptional items was
15.6 % which mirrors the previous year's high level.
Outlook - Continued progression in growth,
profitability improvement and operating cash flow
generation
Clariant expects the good economic environment in mature markets,
which represent a high comparable base, to continue. Emerging
markets are expected to be supportive with Latin America showing
signs of a recovery.
For
2018, Clariant is confident to be able to achieve growth in local
currency, as well as progression in operating cash flow, absolute
EBITDA and EBITDA margin before exceptional items.
Clariant confirms its mid-term target of reaching a position in the
top tier of the specialty chemicals industry. This corresponds to
an EBITDA margin before exceptional items in the range of 16 %
to 19 % and a return on invested capital (ROIC) above the peer
group average.
Corporate Media Relations |
Investor Relations |
Jochen Dubiel
Phone +41 61 469 63 63
jochen.dubiel@clariant.com |
Anja Pomrehn
Phone +41 61 469 67 45
anja.pomrehn@clariant.com |
Thijs Bouwens
Phone +41 61 469 63 63
thijs.bouwens@clariant.com |
Maria Ivek
Phone +41 61 469 63 73
maria.ivek@clariant.com |
|
|
Q1 2018 Media Release
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Clariant AG via Globenewswire
--- End of Message ---
Clariant AG
Rothausstrasse 61 Muttenz 1 Switzerland
ISIN: CH0012142631;
Celsion (AMEX:CLN)
Historical Stock Chart
From Apr 2024 to May 2024
Celsion (AMEX:CLN)
Historical Stock Chart
From May 2023 to May 2024